Search Videos and More
News
How small muscles make a big impact for athletes at any level
Core Stability and the Kinetic Chain
News
Developmental ‘switch’ in brain may shape lifelong obesity risk
UT Southwestern researchers discover regulator in hypothalamus that guides neurons toward appetite-stimulating fates
Video
Excellence in Stroke Care at UT Southwestern
UT Southwestern is a regional referral center for cerebrovascular disorders and an Advanced Comprehensive Stroke Center, which means we offer the highest level of care available.
News
Study finds gaps in concussion reporting across Texas high schools
Socioeconomic differences, awareness, and access to resources may be factors, UTSW researchers say
News
UT Southwestern honors PM&R mentor at Leaders in Clinical Excellence Awards
Among the seven major awards presented in November 2025, Benjamin Nguyen, M.D., Professor in the Department of Physical Medicine and Rehabilitation, was recognized for his outstanding dedication to mentoring and advancing the academic careers of medical students and trainees throughout North America.
News
When Neurology Informs Psychiatry: Lessons from Movement Disorders in Treatment-Resistant Obsessive-Compulsive Disorder and Depression
Treatment-resistant obsessive-compulsive disorder (OCD) and depression numbers continue to rise, leaving families and physicians desperate for answers and uncertain about next therapeutic steps. A neurology team at UT Southwestern’s Peter O’Donnell Jr. Brain Institute has risen to the challenge and is following clues from other brain disorders to evaluate and introduce new therapies that can restore quality of life.
News
Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor for Lowering LDL Cholesterol in Adults with or at Risk for ASCVD: The Phase 3 CORALreef Lipids Trial
A new oral medication may offer people with prior cardiovascular disease or those at high risk an effective alternative to injectable PCSK9 inhibitors for lowering LDL (“bad”) cholesterol, according to late-breaking clinical trial results we presented at #AHA25. Many patients with or at risk for ASCVD continue to fall short of guideline-recommended LDL targets. As a result, these patients remain at high residual risk for heart attacks and strokes.
News
Changes in circadian rhythms linked to higher dementia risk
Study co-led by UTSW researcher highlights new application of heart-monitor data in identifying daily activity changes tied to dementia
News
First patient in Texas receives new treatment for metastatic uveal melanoma at UT Southwestern
Uveal melanoma is a rare cancer that develops in ocular cells that create melanin. It accounts for about 5% of U.S. melanoma cases. About 50% of patients with uveal melanoma are at risk for metastatic disease, sometimes years after successful treatment of the primary eye tumor. Tumors spread to the liver in up to 90% of metastatic uveal melanoma cases.
News
UT Southwestern’s Siegwart Lab is Building Tomorrow’s Cancer Cures From the Inside Out
The Siegwart Lab Program in Genetic Drug Engineering uses nanoparticle technology to create anti-cancer medicines generated within the human body.
News
Simmons Cancer Center earns exceptional rating in its renewal as an NCI-designated Comprehensive Cancer Center
National Cancer Institute reaffirms UT Southwestern’s place among the country’s elite comprehensive cancer centers
News
Perioperative Hemostasis Management During Open Mitral Valve Replacement in a Patient With Hypoprothrombinemia Secondary to Lupus Anticoagulant
Drawing on the multidisciplinary, team-based approach to complex care that UT Southwestern is known for, Dr. Heid partnered closely with colleagues in hematology/oncology and anesthesiology to develop and execute a highly coordinated treatment plan that ultimately saved the patient’s life. The case was authored by Dr. Heid and published, contributing new knowledge to the global clinical community: